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Whole-exome sequencing identifies 
two novel mutations in KCNQ4 in 
individuals with nonsyndromic 
hearing loss
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Jae Hyun Lee1, Jieun An2, Ami Kim2, Joon Suk Lee3, Sun Young Joo3, Seyoung Yu3, 
Jae Young Choi1, Tong Mook Kang2 & Heon Yung Gee  3
Mutations in potassium voltage-gated channel subfamily Q member 4 (KCNQ4) are etiologically linked 
to a type of nonsyndromic hearing loss, deafness nonsyndromic autosomal dominant 2 (DFNA2). We 
performed whole-exome sequencing for 98 families with hearing loss and found mutations in KCNQ4 
in five families. In this study, we characterized two novel mutations in KCNQ4: a missense mutation 
(c.796G>T; p.Asp266Tyr) and an in-frame deletion mutation (c.259_267del; p.Val87_Asn89del). 
p.Asp266Tyr located in the channel pore region resulted in early onset and moderate hearing loss, 
whereas p.Val87_Asn89del located in the N-terminal cytoplasmic region resulted in late onset and 
high frequency-specific hearing loss. When heterologously expressed in HEK 293 T cells, both mutant 
proteins did not show defects in protein trafficking to the plasma membrane or in interactions with 
wild-type (WT) KCNQ4 channels. Patch-clamp analysis demonstrated that both p.Asp266Tyr and 
p.Val87_Asn89del mutant channels lost conductance and were completely unresponsive to KCNQ 
activators, such as retigabine, zinc pyrithione, and ML213. Channels assembled from WT-p.Asp266Tyr 
concatemers, like those from WT-WT concatemers, exhibited conductance and responsiveness to KCNQ 
activators. However, channels assembled from WT-p.Val87_Asn89del concatemers showed impaired 
conductance, suggesting that p.Val87_Asn89del caused complete loss-of-function with a strong 
dominant-negative effect on functional WT channels. Therefore, the main pathological mechanism may 
be related to loss of K+ channel activity, not defects in trafficking.
Hearing loss, a common sensorial disorder with an incidence of 1 in 500–1000 individuals worldwide1, is genet-
ically and clinically heterogeneous. At least half the cases are attributable to genetic factors, and more than 
two-thirds of such cases are classified as nonsyndromic hearing loss (NSHL)2. Among NSHL, approximately 
20% are transmitted as autosomal dominant traits; more than 60 loci for autosomal dominant NSHL (ADNSHL) 
have been mapped, and about 30 genes have been identified as causing ADNSHL if mutated (http://hereditary-
hearingloss.org/). Mutations in WFS1, KCNQ4, COCH, and TECTA are frequently detected in individuals with 
ADNSHL3 and may cause mild to moderate hearing loss.
KCNQ4 (MIM 600101, Kv7.4) is a voltage-gated potassium channel that plays essential roles in maintaining 
ion homeostasis and regulating hair cell membrane potential4. KCNQ4 mutations cause deafness nonsyndromic 
autosomal dominant 2 (DFNA2), which is characterized by progressive sensorineural hearing loss at all frequen-
cies4,5. Kcnq4−/− mice exhibit degeneration of outer hair cells and progressive hearing loss6. Approximately 30 
mutations in KCNQ4 have been reported (http://www.hgmd.cf.ac.uk/ac/index.php and https://www.ncbi.nlm.
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nih.gov/clinvar/, Table S1). KCNQ4 protein consists of six transmembrane domains and pore region7, most muta-
tions are in the pore region8.
The pathogenic mechanism of hearing loss associated with KCNQ4 mutation involves inhibition of the normal 
function of wild-type (WT) KCNQ47. However, several mutations located in the N-terminal cytoplasmic region 
are related to haploinsufficiency9,10. The genotype-phenotype correlation has not been clearly elucidated. Thus, in 
this study, we performed whole-exome sequencing (WES) to identify novel mutations in KCNQ4 among Korean 
families with ADNSHL.
Methods
Patients and diagnosis of sensorineural hearing loss. This study was approved by the institutional 
review board of the Severance Hospital, Yonsei University Health System (IRB#4-2015-0659). All research was 
performed in accordance with relevant regulations of the Severance Hospital. After obtaining informed consent, 
individuals with hearing loss were enrolled in the Yonsei University Hearing Loss (YUHL) cohort, and their clin-
ical and pedigree data were recorded. All patients who were registered in YUHL cohort had bilateral hearing loss 
and were referred to Severance Hospital for further evaluation and treatment (n = 342). Pure tone audiogram and 
auditory brainstem response analyses were performed for all patients and their unaffected family members. We 
obtained audiometric data for all participants. Pure-tone air (250–8000 Hz) and bone conduction (250–4000 Hz) 
thresholds were measured with clinical audiometers in a double-walled audio booth. The degree of hearing loss 
was determined by averaging the thresholds at 500, 1000, 2000, and 4000 Hz of air conduction. In addition, tem-
poral bone computed tomography and magnetic resonance imaging were performed.
DNA preparation, WES, sequence alignment, and variant calling. Whole blood (3 ml) was 
obtained from the affected individuals and their parents. Genomic DNA was extracted from peripheral leuko-
cytes using RBC Lysis Solution, Cell Lysis Solution, and Protein Precipitation Solution (iNtRon Biotechnology, 
Inc). Whole-exome capture was performed using an Agilent SureSelect V5 enrichment capture kit (Agilent 
Technologies, Santa Clara, CA, USA), and the enriched library was then sequenced using an Illumina HiSeq. 
2500 instrument (101 bases paired end). Variant filtering was carried out as described previously11. In the first 
step, variants with minor allele frequencies >1% in the gnomAD database (http://gnomad.broadinstitute.org/) 
were excluded. In the second step, variants present in the homozygous or hemizygous state in 32 healthy Korean 
individuals without hearing loss (internal control WES data) were excluded. In the third step, synonymous vari-
ants and intronic variants not located within the splice site regions were excluded. In the fourth step, variants of all 
144 genes known to be monogenic factors for hearing loss were systematically evaluated (Table S2). The process 
for variant filtering is described in Table S3.
Three-dimensional structure modeling. To examine structural changes in KCNQ4 protein, 
three-dimensional protein modeling was performed for the ion transport domain of KCNQ4. A BLAST sequence 
search against the protein data bank (PDB) was performed to select the template structure with the closest 
sequence similarity to the domain of KCNQ4. The structural model for the full-length SHAKER potassium chan-
nel Kv1.2 from Rattus norvegicus (PDB ID: 3LUT) was then selected. The sequence similarity between these 
domains was 33%. SWISS-MODEL was used to generate the tertiary structure of the domains (SWISS-MODEL, 
http://swissmodel.expasy.org/). Modeling of the ion transport domain-p.Asp266Tyr was based on the PDB tem-
plate files. Molecular graphics and analyses were performed using the USCF Chimera package (Chimera, http://
www.cgl.ucsf.edu/chimera).
Plasmid construction and site-directed mutagenesis. cDNAs for human KCNQ4 were purchased 
from OriGene Technologies (Rockville, MD, USA). cDNA was subcloned into the pENTR-D-TOPO vector 
(Invitrogen, Carlsbad, CA, USA). Expression vectors were created using LR clonase (Invitrogen) following the 
manufacturer’s instructions. Clones reflecting the KCNQ4 mutations identified in individuals with NSHL were 
introduced in the cDNA constructs in the pENTR-D-TOPO vector using a Quick change II XL site-directed 
mutagenesis kit (Agilent Technologies). Tandem concatemers of KCNQ4 WT subunits or of one WT and one 
mutant subunit were generated by fusing the subunits C-terminus to N-terminus.
Cell culture and transfection. Human embryonic kidney 293 T (HEK293T) and HeLa cells were cul-
tured in Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum and penicillin (50 IU/
ml)/streptomycin (50 μg/ml; Invitrogen). The cells were transfected with WT or mutant KCNQ4 plasmids using 
Lipofectamine PLUS reagent (Invitrogen) according to the manufacturer’s instructions. To analyze the electro-
physiological properties of homotetrameric KCNQ4 channels, KCNQ4 WT, p.Asp266Tyr, and p.Val87_Asn89del 
were cloned into the pRK5 vector and transiently expressed with pEGFPN-1 in HEK293T cells. Similarly, three 
tandem concatemers fused with WT KCNQ4 (WT-WT, WT-p.Asp266Tyr, and WT-p.Val87_Asn89del) were 
cloned into the pRK5 vector and transiently expressed in HEK293T cells with pEGFPN-1. HEK293T cells trans-
fected with empty pRK5 vectors and green fluorescent protein (GFP) were used as a control group.
Immunoblotting, immunoprecipitation, surface biotinylation, and immunofluorescence. 
Experiments were performed as described previously12. Anti-binding immunoglobulin protein (BiP; ab21685; 
Abcam, Cambridge, UK), anti-β-actin (ab6276; Abcam), anti-Myc (sc-40; Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), anti-adolase A1 (sc-12059; Santa Cruz Biotechnology), anti-golgin B1 (GOLGB1; HPA011008, 
Sigma, St. Louis, Mo, USA), and anti-FLAG (F3165; Sigma) antibodies were purchased from commercial sources. 
Co-immunoprecipitation was performed using EZview Red Anti-FLAG M2 and Anti-c-Myc Affinity Gel 
(Sigma). Surface biotinylation was performed using 0.3 mg/ml EZ-Link Sulfo-NHS-SS-Biotin and NeutrAvidin 
(Thermo Scientific). Immunoblotting was performed using primary antibodies at 1:1000 dilution followed by the 
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corresponding anti-isotype secondary antibodies (Santa Cruz Biotechnology) at 1:2000 dilution. Signals were 
visualized using the SuperSignal West-Pico kit (Thermo Scientific). Confocal images were obtained with a Carl 
Zeiss LSM780 microscope, and ZEN was used for image analysis.
Whole-cell patch clamp assays. KCNQ4 ionic currents were measured with a conventional whole-cell 
patch clamp technique. HEK293T cells were transiently transfected with KCNQ4 plasmids using Lipofectamine 
and seeded onto poly-l-lysine-coated recording chambers mounted on an inverted microscope (IX-70; Olympus, 
Japan). A healthy-looking cell with green fluorescence (GFP) was selected for whole-cell patch clamp recording. 
Recording patch pipettes were pulled from borosilicate glass tubing (WPI, Sarasota, FL, USA), and the pipette 
tip was fire-polished with a microforge (MF-83; Narishige, Japan). The final pipette tip resistance was 1.5–3 MΩ. 
After achieving conventional whole-cell patch clamp configuration, whole-cell K+ currents were amplified and 
recorded with an Axopatch-1D amplifier (Axon Instrument, USA). The currents were filtered at 5 KHz and 
acquired at a sampling rate of 10 kHz. Before acquiring ionic currents, series resistance was compensated, and 
the cell membrane capacitance (Cm) was measured and cancelled using a circuit of the patch-clamp amplifier. 
K+ currents were generated with 2-s depolarizing voltage steps ranging from −70 to +40 mV in 10-mV incre-
ments, followed by a 1-s hyperpolarizing voltage step to −50 mV. Step voltage pulses were generated every 10 s. 
All recordings were performed at room temperature (~23 °C). Recorded currents were analyzed using Clampex 
software (pCLAMP 7.0; Axon Instrument). To isolate KCNQ4-mediated K+ current from the total whole-cell 
currents, linopirdine (30 μM) was administrated into the cells, and the linopirdine-sensitive component was 
obtained by digital subtraction. For comparison, KCNQ4 current densities (pA/pF) were calculated by divid-
ing the KCNQ4 steady-state current amplitudes recorded at +40 mV with the measured Cm. The relationship 
between normalized conductance (G/Gmax) and voltage (V) was calculated from the I-V curve of the current, and 
the half-activation voltage (V1/2) of the channel was calculated by fitting to a Boltzmann function.
Solutions and chemicals used for patch clamp study. The external bath solution for whole-cell patch 
clamp recording consisted of 147 mM NaCl, 5 mM KCl, 1.5 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10 mM 
d-glucose, adjusted to pH 7.4 with N-methyl-d-glucamine. The internal patch pipette solution contained 130 mM 
KCl, 10 mM NaCl, 10 mM EGTA, 10 mM HEPES, 3 mM Mg-ATP, 0.5 mM CaCl2, adjusted to pH 7.2 with KOH. 
The calculated free Ca2+ concentration was about 10 nM.
Linopirdine dihydrochloride (Tocris Bioscience, Bristol, UK), retigabine (Glentham Life Science, Corsham, 
UK), and zinc pyrithione (Sigma-Aldrich, St. Louis, MO, USA), and ML213 (Tocris Bioscience) were dissolved in 
DMSO and prepared as 5–30 mM stock solutions. Each stock solution was diluted into the external bath solution 
before use.
Statistics. The obtained values were expressed as means ± standard errors of the means. The data were plot-
ted and analyzed with Origin software (version 6.1; OriginLab, USA). Statistical significance was determined by 
paired or unpaired Student’s t-tests, and differences with P values of less than 0.05 were considered significant.
Results
WES identified autosomal dominant mutations in KCNQ4. 342 families with hearing loss have been 
enrolled in the YUHL cohort, and GJB2 and SLC26A4 were examined by Sanger sequencing as these are most 
common cause of hearing loss in Korea11. We performed WES for 98 families in which GJB2 and SLC26A4 were 
excluded. In 38 of 98 families including YUHL35 and YUHL41 (Fig. 1), autosomal dominant inheritance was 
suspected based on pedigrees. WES detected potentially causative mutations in KCNQ4 in five families, there-
fore, 13.1% (5/38) of families suspecting an autosomal dominant inheritance were explained by KCNQ4 muta-
tions. Missense variant (c.796 G>T; p.Asp266Ty) and an in-frame deletion variant (c.259_267delGTCTACACC; 
p.Val87_Asn89del) were detected in YUHL35 II-6 and YUHL41 III-2, respectively (Table 1). Other variants in 
known genes were excluded (Table S4). Both variants in KCNQ4 have not been reported in any public databases 
and were segregated with the affected status (Table 1 and Fig. S2). The amino acid residues deleted by the in-frame 
deletion mutation were conserved throughout evolution (Fig. 1a). Both KCNQ4 variants identified in this study 
had not been previously reported, therefore, their pathogenicity should be examined. The other three families 
shared a same KCNQ4 mutation which has not been reported yet and we are currently investigating the patho-
genicity of this mutation.
We first performed a computational tertiary structure prediction of WT and mutant KCNQ4 proteins. The 
Asp residue at position 266 of KCNQ4 protein was in the ion permeating pore domain and formed a hydrogen 
bond with Lys289 (Fig. 1b). However, the p.Asp266Tyr mutant formed hydrogen bonds with Asp272, Ser273, 
and Lys289 (Fig. 1c). Moreover, Lys289 clashed with the amino acid substitution from Asp to Tyr at position 266.
Audiological phenotype and clinical assessment. The pedigree of YUHL35 revealed the autosomal 
dominant nature of hearing loss (Fig. 1d). Affected patients (II-6 and III-7) had moderate bilateral sensorineural 
hearing loss; II-6 had down-sloping hearing loss with an acoustic threshold of 50 dB HL through all frequencies, 
whereas III-7 had only mid-frequency hearing loss up to 60 dB HL (Fig. 1e–g). The ages of onset were the early 
second and first decades for II-6 and III-7, respectively. II-6 had bilateral progressive hearing deterioration during 
the follow-up period (Fig. S1). Both II-6 and III-7 had no vestibular symptoms.
In the YUHL41 family, ADNSHL was associated with high-frequency hearing loss (Fig. 1h). Affected individ-
uals had symmetric down sloping hearing loss up to 60 dB HL; hearing functions at 250 and 500 Hz were well pre-
served in all unaffected cases (Fig. 1i–l). Interestingly, II-2 and III-2 exhibited similar hearing thresholds although 
there was a three-decade age difference, implying that hearing loss was not progressive.
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Figure 1. KCNQ4 mutations identified by whole-exome sequencing, and pedigrees and audiological 
phenotypes of YUHL35 and YUHL41 families. (a) Evolutionary conservation of altered amino acid residues 
of KCNQ4. (b,c) Computational tertiary structure prediction of KCNQ4 wild-type and p.Asp266Tyr proteins. 
Asp266 shared a hydrogen bond with Lys289 (K), whereas p.Asp266Tyr had hydrogen bonds with Asp272, 
Ser273, and Lys289 (L). Moreover, Lys289 clashed with the p.Asp266Tyr mutation. YUHL, Yonsei University 
hearing loss. (d) The family pedigree of YUHL35 with autosomal dominant hearing loss. KCNQ4 genotypes 
of individuals in whom Sanger sequencing was performed are indicated. (e–g) The pure-tone audiogram 
showed moderate sensorineural hearing loss bilaterally in II-6 (f). Note that the 8-year-old male only had mid-
frequency hearing loss up to 60 dB HL (g). (h) An autosomal dominant inheritance pattern was observed in the 
YUHL41 pedigree. KCNQ4 genotypes of individuals in whom Sanger sequencing was performed are indicated. 
(i–l) Affected individuals II-2 (i) and III-2 (l) had residual hearing function at 250 and 500 Hz, whereas hearing 
loss at high frequencies was observed in pure-tone audiograms.
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Effects of the identified mutations on the surface expression and subunit interactions of 
KCNQ4. To evaluate the impact of the identified mutations on trafficking of KCNQ4 to the plasma membrane, 
we performed surface biotinylation of WT and mutant KCNQ4 proteins in HEK293 cells. When overexpressed, 
both mutant proteins and the WT protein showed cell surface expression (Fig. 2a). The absence of the cytosolic 
protein aldolase A in the biotinylated fraction confirmed cell surface protein-specific labeling. In addition, there 
were no differences in expression levels between WT and mutant proteins.
Immunofluorescence analysis showed that both mutant proteins and the WT protein were localized to the 
plasma membrane (Figs 2b and S3). p.Val87_Asn89del mutant protein reached the cell surface, although a signifi-
cant portion of the protein seemed to be trapped in the endoplasmic reticulum (ER) or Golgi apparatus, as shown 
by colocalization with the ER marker Calnexin and Golgi marker Giantin, respectively (Fig. 2b). The Val-Tyr-Asn 
residues at positions 87–89 of KCNQ4 are also conserved in KCNQ1 and these amino acid residues are a part 
of the N-terminal juxtamembranous domain which is critical for surface expression of KCNQ113. Therefore, we 
compared p.Val87_Asn89 mutant protein with a known trafficking mutant (ΔF508) of cystic fibrosis transmem-
brane conductance regulator (CFTR)14. The expression level of ΔF508-CFTR was significantly increased by the 
proteosomal inhibitor MG132, whereas those of WT-CFTR, WT and mutant KCNQ4 proteins were not affected 
by MG132 (Fig. S4). The amount of p.Val_Asn89del mutant protein was not changed by the lysosomal inhibitor 
leupeptin (Fig. S4a).
The functional potassium channel is formed by a tetrameric assembly of KCNQ4 subunits9. Individuals with 
KCNQ4 mutations were heterozygous (Fig. S2), and expression levels of mutant proteins were comparable to that 
of the WT protein (Fig. 2a). Therefore, WT or mutant Myc-tagged KCNQ4 clones were cotransfected with the WT 
FLAG-KCNQ4 clone into HEK293T cells. The heteromeric assembly was analyzed by co-immunoprecipitation. 
Similar to WT protein, both p.Val87_Asn89del and p.Asp266Tyr proteins showed normal ability to interact with WT 
protein, suggesting that tetramerization between WT and mutant proteins was unlikely to be disrupted (Fig. 2c,d).
Effects of the identified mutations on KCNQ4 channel conductance. Ion conductance of 
homomeric mutant channels was compared with that of the functional WT KCNQ4 channel. In conventional 
whole-cell patch clamp recordings, KCNQ4 mutant channels could not generate appreciable K+ currents (Fig. 3). 
After subtraction of the linopirdine-sensitive component from the total K+ current, the I-V curve of the WT 
KCNQ4-mediated K+ current showed a typical curve of KCNQ4 channels (Fig. 3a,b). However, similar to 
GFP-transfected cells, p.Asp266Tyr and p.Val87_Asn89del mutant channels produced barely detectable currents 
(Fig. 3c). Furthermore, these two mutant channels were not activated by known KCNQ openers (10 μM retiga-
bine, 3 μM ML213, and 10 μM zinc pyrithione)15–18. Combination of retigabine or ML213 with zinc pyrithione 
further increased WT-mediated current in an additive manner. However, none of the combinations activated 
the current in either mutant (Fig. 3d–g). These findings suggest that both p.Asp266Tyr and p.Val87_Asn89del 
channels were loss-of-function mutants.
Dominant-negative effects of the mutant KCNQ4 channels. To evaluate the dominant-negative 
effects of the mutant channels, p.Asp266Tyr and p.Val87_Asn89del mutants were individually co-expressed 
with the WT KCNQ4 channel at different cDNA molar ratios (WT:mutants ratios ranged from 4:0 to 0:4). By 
increasing the amounts of mutant cDNA (p.Asp266Tyr or p.Val87_Asn89del), recorded linopirdine-sensitive 
K+ currents were gradually reduced. Below WT:mutants cDNA ratios of 1:3, the measured current size was not 
significantly different from that of cells with the empty vector (Fig. 4a,b). The measured KCNQ4-mediated K+ 
Gene 
symbol Family Sex
Age of 
onset
Nucleotide 
changea
Amino  
acid  
change
Exon 
(zygosity, 
segregation) GERPb PhyloPc
Frequencies 
in the dbSNP 
databased
Frequencies 
in the 
gnomAD 
databasee
Frequencies 
in the NBK 
databasef PP2g MTh PROVEANi SIFTj
KCNQ4
YUHL 
35 Fm 30 yr c.796G>T
p. 
Asp266Tyr 5 (het, ND) 5.08 4.749 ND ND ND
PD 
(0.980)
DC 
(0.999) Del (−2.96)
Dam 
(0.001)
YUHL 
41 Fm
Early 1st 
decade
c.259_267del 
GTCTACAAC
p.Val87_
Asn89del 1 (het, F) NA NA ND ND ND NA
PM 
(0.866) Del (−17.62) NA
Table 1. Mutations in KCNQ4 detected in individuals with nonsyndromic hearing loss by WES. Abbreviations 
are as follows: Dam, damaging; DC, disease causing; Del, deleterious; F, heterozygous mutation identified in 
the father; Fm, female; het, heterozygous in the affected individual; M, heterozygous mutation identified in the 
mother; MT, Mutation Taster; NA, not applicable; ND, no data or DNA available; PD, probably damaging; PM, 
polymorphism; PP2, PolyPhen-2 prediction score Humvar; PROVEAN, Protein Variation Effect Analyzer; 
SIFT, Sorting Intolerant from Tolerant; SNP, single nucleotide polymorphism; yr, years; YUHL, Yonsei 
University Hearing Loss cohort. acDNA mutations are numbered according to the human cDNA reference 
sequence NM_004700.3 (KCNQ4); +1 corresponds to the A of ATG translation initiation codon. bGenomic 
Evolutionary Rate Profiling (GERP) score. bPhyloP100way_vertebrate score. ddbSNP database (http://www.
ncbi.nlm.nih.gov/SNP). egenome Aggregation Database browser (http://gnomad.broadinstitute.org/). fNational 
Biobank of Korea (NBK), Centers for Disease Control and Prevention. gPolyPhen-2 (PP2) prediction score 
HumVar ranges from 0 to 1.0; 0 = benign, 1.0 = probably damaging (http://genetics.bwh.harvard.edu/pph2/). 
hMutation taster (http://www.mutationtaster.org/). iPROVEAN, (http://provean.jcvi.org/index.php). jSIFT, 
(http://sift.jcvi.org/).
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currents at different WT:mutant ratios were deviated from the predicted suppression ratios for a tetrameric 
co-assembly of WT with dominant-negative KCNQ4 subunits (Fig. 4c). This result did not support the notion 
that individual mutant channels had classical dominant-negative effects. However, the variance and outliers in 
current density values within the same group made it difficult to reach a definitive conclusion.
To overcome this limitation, we generated tandem concatemers of the mutants fused with the C-terminal end 
of the WT channel and examined whether these mutant channels had dominant-negative effects with a forced 2:2 
assembly. Importantly, protein synthesis and surface expression of the concatemers were not defective (Fig. S5). 
In patch-clamp assays, the linopirdine-sensitive K+ current generated by the control WT-WT concatemer was 
nearly equivalent to the current size of homomeric WT channels (Fig. 5). Although homomultimeric p.Asp-
266Tyr channels had impaired conductance (Fig. 3a), KCNQ4 channels assembled from the WT-p.Asp266Tyr 
concatemer exhibited 70% of the linopirdine-sensitive K+ current of channels assembled from WT-WT concate-
mers (Fig. 5b). Thus, forced 2:2 assembly of WT and p.Asp266Tyr mutant subunits almost completely restored 
channel conductance. In contrast, channels assembled from WT-p.Val87_Asn89del concatemers exhibited 
Figure 2. Surface expression and subunit interactions of WT and mutant KCNQ4 proteins. HEK293T or 
HeLa cells were transfected with N-terminally Myc- or Flag-tagged WT and mutant KCNQ4 clones. (a) Cell 
surface biotinylation in HEK293T. Proteins on the plasma membrane were labelled with biotin, isolated with 
avidin beads, and assessed by western blotting. Surface expression of two mutant KCNQ4 proteins was similar 
to that of WT protein. (b) Immunofluorescence of WT and mutant KCNQ4 proteins in HeLa cells. Cells were 
immunostained with anti-Myc, anti-calnexin, and anti-giantin antibodies. Nuclei were stained with DAPI. 
Calnexin and giantin are markers for the endoplasmic reticulum and Golgi apparatus, respectively. Both mutant 
KCNQ4 proteins and WT protein were observed on the plasma membrane. (c–d) Subunit interactions between 
WT and mutant KCNQ4 proteins. Twenty-four hours post-transfection, whole-cell lysates were subjected 
to immunoprecipitation using anti-Myc (c) or anti-FLAG (d) antibodies and immunoblotted. Both KCNQ4 
mutant proteins interacted with WT protein.
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impaired conductance similar to p.Val87_Asn89del homomultimeric channels and produced a negligible current 
size similar to that of GFP-transfected cells (Figs 3 and 5). Therefore, we concluded that the p.Val87_Asn89del 
mutant had strong dominant-negative effects on functional WT channels.
Figure 3. Impaired potassium conductance of homomeric mutant KCNQ4 channels. (a) Whole-cell KCNQ4 
K+ current traces recorded from the HEK293T cells transiently expressing WT, p.D266Y, p.V87_N89del, 
or GFP. Homomeric p.Asp266Tyr and p.Val87_Asn89del mutant channels produced barely detectable K+ 
currents. (b,c) Current-voltage (I-V) relationships of linopirdine (30 μM)-sensitive K+ currents (b), and current 
densities measured at +40 mV (c). The I-V curve of the WT protein exhibited a typical outwardly rectifying 
KCNQ4 channel current, and the current densities of p.D266Y and p.V87_N89del mutants were not significant 
(NS) compared with GFP. WT, n = 24; p.D266Y, n = 10; p.V87_N89del, n = 10; GFP, n = 22. *P < 0.05 versus 
mutants and GFP. (d–g) Homomeric mutant channels were not activated by known KCNQ openers. Single or 
combination treatment with retigabine (Ret, 10 μM), ML213 (3 μM), and zinc pyrithione (ZnPy, 10 μM) did not 
activate mutant channels (d,f), and the current densities after treating KCNQ openers were not significantly 
different from that of GFP (e,g). Mean ± SEM, n = 6–9; **P < 0.01 and ***P < 0.005 versus the WT protein.
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Pharmacological responses to KCNQ activators (retigabine, ML213, zinc pyrithione) were similar between 
WT-p.Asp266Tyr and WT-WT concatemers (Fig. S6). Single or combination treatments of KCNQ activators 
increased the WT-WT and WT-p.Asp266Tyr concatemer-mediated current to a similar extent (Fig. S6b). Every 
KCNQ opener used in this study shifted the activation curves of the WT-WT and WT-p.Asp266Tyr concate-
mer channels to the hyperpolarizing voltage. The extent of hyperpolarizing movement of half-activation voltages 
(V1/2) was similar between these two concatemers (Fig. S6c,d). In contrast, WT-p.Val87_Asn89del concatemers 
were not activated by any combination of KCNQ4 openers (Fig. S6a,b). Consistent with this finding, no shift or 
movement in the activation curves of the WT-p.Val87_Asn89del was detected.
Taken together, our patch-clamp study suggested that the new mutations p.Asp266Tyr and p.Val87_Asn89del 
in KCNQ4 resulted in complete loss-of-function and that p.Val87_Asn89del exerted dominant-negative effects 
on WT channels.
Discussion
We identified novel mutations (c.796G>T; p.Asp266Ty and c.259_267delGTCTACACC; p.Val87_Asn89del) 
in KCNQ4 in patients with NSHL. The position of the affected amino acid residues was well conserved across 
species.
DFNA2-associated hearing loss involves pathogenic mutations in KCNQ47,19. To date, there are 28 pathogenic 
KCNQ4 mutations associated with DFNA2 (http://deafnessvariationdatabase.org/). Most mutations are found in 
a single family, and some recurrent mutations, such as p.Trp276Ser, have been designated by the term “hot spot 
mutations” in KCNQ44,7,9,20–23. However, in a recent report, c.211delC was identified as a recurrent mutation due 
to the common ancestor effect in Japanese individuals21. Indeed, c.211delC mutations were found in seven of 13 
families with DFNA2-associated KCNQ4 mutations. Notably, the prevalence of mutations in KCNQ4 is as high 
as 6.67% in Japan and in our YUHL cohort, KCNQ4 mutations were detected in families in which autosomal 
dominant inheritance was suspected. Thus, screening for mutations in KCNQ4 should be considered to identify 
causative mutations in ADNSHL.
The main pathogenic mechanism of mutations in KCNQ4 is the dominant-negative effect of the mutant pro-
tein6,7. Because KCNQ4 potassium channels form homotetramers6,9, 1/16 [(1/2)4] of potassium channels can 
Figure 4. Dominant-negative effects of the mutant KCNQ4 channels. (a) Individual mutants (p.D266Y and 
p.V87_N89del) were co-expressed with WT KCNQ4 at the indicated WT:mutant cDNA molar ratios, and 
linopirdine-sensitive K+ current traces were recorded at +40 mV. Dashed lines indicate zero current levels. 
(b) Comparison of current densities at +40 mV. WT:mutant cDNA ratios are indicated under the bar graphs, 
and the total amount of cDNA was equalized in all groups by adding empty vector (pRK5). (c) Suppression of 
WT-mediated current by the co-expression of mutant (Mt) KCNQ4 channels. The mean values of the current 
densities obtained at +40 mV were normalized, and the current suppression ratios were denoted against 
WT/(WT + mutant) ratios of cDNA transfected. Dashed line with a square symbol denotes the predicted 
suppression ratio expected for the tetrameric channel. Mean ± SEMs (n = 10–24).
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function normally, possibly contributing to slow progressive hearing loss in patients with heterozygous mutations 
in KCNQ4. In knock-in mouse models and heterologously expressed cell line models, missense mutations were 
found to inhibit KCNQ4 channel function through dominant-negative effects6,24. Specifically, missense mutations 
in the pore region of KCNQ4 result in early-onset disease and severe hearing loss9,25. However, some deletion 
mutations are correlated with late onset and mild hearing loss, implying that haploinsufficiency is the pathogenic 
mechanism of DFNA29,10. Thus, the mild phenotype of DFNA2 is likely correlated with truncating mutations in 
the N-terminal cytoplasmic domain due to the null function of mutant proteins without interfering with WT 
KCNQ4.
In this study, we found an in-frame three-amino acid deletion mutation (p.Val87_Asn89del) in the N-terminal 
cytoplasmic domain of KCNQ4, which caused high frequency-specific hearing loss with normal hearing at low 
frequency (YUHL41 family). Additionally, p.Val87_Asn89del mutant KCNQ4 had a strong dominant-negative 
effect in electrophysiological studies, which likely caused high frequency-specific hearing loss. Given that KCNQ4 
in outer hair cells is evenly expressed in both basal and apex turns of the cochlea, high frequency-specific hearing 
loss is hardly explained only by changes in the expression of KCNQ4 in the outer hair cells. In addition, some 
patients with DFNA2 show both low and high frequency-hearing loss; therefore, the genotype-phenotype cor-
relation in patients with DFNA2 is highly complex. This complex nature of the phenotypes in DFNA2 may be 
attributable to the gradient expression of KCNQ4 in spiral ganglion cells as well as in inner hair cells26,27.
As in many voltage-gated ion channels, the highly conserved cytoplasmic N-terminal S0 segment is found in 
KCNQ family channels. The S0 helix segment is considered as a critical scaffolding element that contributes to 
the structural stability and dynamics of other voltage sensor domains (S1–S4 segments)28,29. A number of cardiac 
long QT syndrome (LQTS)-associated KCNQ1 variants located in the S0 segment dysregulate channel function 
by impairing surface expression or by negatively affecting channel conduction. In particular, KCNQ1 mutations 
in the C-terminal half of the S0 segment tend to produce severe defects of protein expression or trafficking29. In 
our study, the three deleted amino acids (Val87-Tyr88-Asn89) of the p.Val87_Asn89del mutation are also located 
in the middle of the S0 segment, and these conserved amino acids correspond to Val110-Tyr111-Asn112 of the 
KCNQ1 S0 segment13,29,30. Therefore, we suspected a trafficking defect in the p.Val87_Asn89del protein. However, 
no defect in the surface expression of p.Val87_Asn89del protein or the formation of heteromultimeric channels 
with WT channels were observed. Consistent with these studies, the WT-p.Val87_Asn89del concatemer channels 
were well detected on the cell surface (Fig. S5).
Instead of defect in membrane expression, electrophysiological studies demonstrated that p.Val87_Asn89del 
is a loss-of-function mutant and its strong dominant-negative effect impairs the channel conductance of heter-
omeric channels. Deleted amino acids in the S0 segment may disrupt the stability of the voltage sensor domain 
Figure 5. Potassium conductance of KCNQ4 channels assembled from tandem concatemers. (a) Representative 
K+ current traces recorded from the KCNQ4 channels assembled from WT-WT, WT-p.D266Y, and WT-p.
V87_N89del concatemers. GFP-transfected cells were used as controls, and linopirdine-sensitive currents were 
subtracted for comparison. (b) Comparison of current densities at +40 mV. Means ± SEMs; WT-WT, n = 13; 
WT-p.D266Y, n = 12; WT-p.V87_N89del, n = 11; GFP, n = 6. NS, not significant; ***p < 0.005 versus WT-WT; 
#p < 0.05 versus WT-D266Y.
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of the channel, thereby impairing the voltage-sensitive gating mechanism. The ineffectiveness of KCNQ openers 
in p.Val87_Asn89del channels may indicate disruption of channel gating properties because the same openers 
shifted the gating voltages of functional channels to the hyperpolarized voltage range (Fig. S6). Cryo-EM struc-
ture and molecular dynamics simulation of the KCNQ1 channel revealed a strong motional coupling between the 
scaffolding S0 segment, the C-terminal half of S2, and the critical voltage-sensing S4 segment28,29. These studies 
emphasized that the S0 segment contributes to the organization and stabilization of the structure of other voltage 
sensor domains (S1-S4). We speculate that the p.Val87_Asn89del mutation causes unavoidable structural disrup-
tion of the S0 segment and destabilizes the interaction with the voltage sensor, thereby failing to facilitate voltage 
sensing and gating. The observed dominant negative effect of the p.Val87_Asn89del mutant can be explained 
by the same principle, i.e., co-assembly of the broken voltage sensor subunit impairs the whole gating process 
of the tetrameric channel. Cryo-EM structure of KCNQ1 unveiled a unique hinge structure located between S4 
and S4–S5 linker28. In the absence of membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2) signaling, 
the hinge permits uncoupling of activated voltage sensors and the closed pore. Therefore, the hinge is an impor-
tant structure for the regulation of PIP2-dependent KCNQ channel gating. From the molecular dynamics study 
of KCNQ1, two residues in the hinge were also found to be S0 segment-interacting sites29. The c.664_681del 
(p.G215_L220del) KCNQ4 mutant was reported previously as a pathogenic mutation in Korean DFNA patients24. 
Like the p.Val87_Asn89del mutant, this dominant-negative mutation resulted in a loss-of-function channel, but 
it showed normal cell surface expression. The p.G215_L220del mutation is located in the hinge that interacts with 
the voltage-sensing S0 segment. Given that these two mutations showed identical biochemical and electrophysio-
logical features (normal protein synthesis, assembly and trafficking of the impaired voltage sensing channels), we 
suggest that they are good examples to emphasize the pathogenic effect of the impaired voltage sensor of KCNQ4 
channel from a perspective of the interaction between the S0 segment and the hinge.
KCNQ4 mutated at the channel pore region produces severely impaired nonconducting channels causing 
severe-to-profound hearing loss in patients with DFNA2. Missense mutations at the K+ ion selectivity filter with 
the GYG signature sequence (p.Gly285Cys, p.Gly285Ser) or pore-helix domain (p.Leu274His, p.Trp276Ser) 
showed complete loss of ion conduction and decreased surface expression. Thus, these mutants exhibit strong 
dominant-negative effects to WT protein, and their impaired conductance was not rescued by co-assembly with 
conducting WT subunits4,5,18,21,31. In the YUHL35 family, the novel KCNQ4 missense mutation at the K+ channel 
pore forming region (p.Asp266Tyr) produced non-conducting homotetrameric KCNQ4 channels and decreased 
the sensitivity to KCNQ channel openers, but did not affect membrane trafficking or the formation of heteromul-
timeric channels with WT subunits. In addition, the channels assembled from WT-p.Asp266Tyr concatemers 
showed conductance comparable to channels assembled from WT-WT concatemers. Because p.Asp266Tyr is 
located at the outer position of the pore loop with preserved normal sequences at the core pore domain, it can 
be speculated that this mutant has the capability to recover its ion conduction unlike other pore mutations, by 
forming heterotetrameric channels with the WT protein. This may explain the relatively mild hearing loss in 
patients with the p.Asp266Tyr mutation, whereas individuals with missense mutations in the core pore domain, 
such as p.Trp276Ser, manifest severe-to-profound hearing loss4,7,9,20–23. It needs further confirmation whether the 
p.Asp266Tyr mutation is truly associated with hearing loss.
In conclusion, WES of patients with ADNSHL identified two novel KCNQ4 mutations (p.Asp266Tyr and 
p.Val87_Asn89del) associated with different audiological phenotypes of DFNA2. Electrophysiology studies 
demonstrated the pathogenicity of these KCNQ4 mutations, indicating causality for ADNSHL.
References
 1. Xing, G. et al. Identification of OSBPL2 as a novel candidate gene for progressive nonsyndromic hearing loss by whole-exome 
sequencing. Genet Med 17, 210–218, https://doi.org/10.1038/gim.2014.90 (2015).
 2. Hilgert, N., Smith, R. J. H. & Van Camp, G. Function and expression pattern of nonsyndromic deafness genes. Current molecular 
medicine 9, 546–564 (2009).
 3. Hilgert, N., Smith, R. J. & Van Camp, G. Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed 
in DNA diagnostics? Mutat Res 681, 189–196, https://doi.org/10.1016/j.mrrev.2008.08.002 (2009).
 4. Kubisch, C. et al. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96, 
437–446 (1999).
 5. Gao, Y., Yechikov, S., Vazquez, A. E., Chen, D. & Nie, L. Impaired surface expression and conductance of the KCNQ4 channel lead 
to sensorineural hearing loss. Journal of cellular and molecular medicine 17, 889–900, https://doi.org/10.1111/jcmm.12080 (2013).
 6. Kharkovets, T. et al. Mice with altered KCNQ4 K+channels implicate sensory outer hair cells in human progressive deafness. The 
EMBO journal 25, 642–652, https://doi.org/10.1038/sj.emboj.7600951 (2006).
 7. Dominguez, L. M. & Dodson, K. M. Genetics of hearing loss: focus on DFNA2. Appl Clin Genet 5, 97–104, https://doi.org/10.2147/
TACG.S35525 (2012).
 8. Wang, H. et al. Targeted high-throughput sequencing identifies pathogenic mutations in KCNQ4 in two large Chinese families with 
autosomal dominant hearing loss. PloS one 9, e103133, https://doi.org/10.1371/journal.pone.0103133 (2014).
 9. Coucke, P. J. et al. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Human 
molecular genetics 8, 1321–1328 (1999).
 10. Kamada, F. et al. A novel KCNQ4 one-base deletion in a large pedigree with hearing loss: implication for the genotype-phenotype 
correlation. J Hum Genet 51, 455–460, https://doi.org/10.1007/s10038-006-0384-7 (2006).
 11. Jung, J. et al. Genetic Predisposition to Sporadic Congenital Hearing Loss in a Pediatric Population. Scientific reports 7, 45973, 
https://doi.org/10.1038/srep45973 (2017).
 12. Gee, H. Y., Tang, B. L., Kim, K. H. & Lee, M. G. Syntaxin 16 binds to cystic fibrosis transmembrane conductance regulator and 
regulates its membrane trafficking in epithelial cells. The Journal of biological chemistry 285, 35519–35527, https://doi.org/10.1074/
jbc.M110.162438 (2010).
 13. Dahimene, S. et al. The N-terminal juxtamembranous domain of KCNQ1 is critical for channel surface expression: implications in 
the Romano-Ward LQT1 syndrome. Circulation research 99, 1076–1083, https://doi.org/10.1161/01.res.0000250262.12219.95 
(2006).
 14. Cheng, S. H. et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 
827–834 (1990).
www.nature.com/scientificreports/
1 1Scientific RepoRTS |         (2018) 8:16659  | DOI:10.1038/s41598-018-34876-9
 15. Gunthorpe, M. J., Large, C. H. & Sankar, R. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener 
for the treatment of epilepsy. Epilepsia 53, 412–424, https://doi.org/10.1111/j.1528-1167.2011.03365.x (2012).
 16. Yu, H. et al. Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: 
Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener. ACS chemical neuroscience 2, 572–577, 
https://doi.org/10.1021/cn200065b (2011).
 17. Xiong, Q., Sun, H. & Li, M. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic 
mutants. Nature chemical biology 3, 287–296, https://doi.org/10.1038/nchembio874 (2007).
 18. Leitner, M. G. et al. Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers. British 
journal of pharmacology 165, 2244–2259, https://doi.org/10.1111/j.1476-5381.2011.01697.x (2012).
 19. Xia, J. H. et al. Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. 
Nat Genet 20, 370–373, https://doi.org/10.1038/3845 (1998).
 20. Van Camp, G. et al. A mutational hot spot in the KCNQ4 gene responsible for autosomal dominant hearing impairment. Human 
mutation 20, 15–19, https://doi.org/10.1002/humu.10096 (2002).
 21. Naito, T. et al. Comprehensive Genetic Screening of KCNQ4 in a Large Autosomal Dominant Nonsyndromic Hearing Loss Cohort: 
Genotype-Phenotype Correlations and a Founder Mutation. PloS one 8, e63231, https://doi.org/10.1371/journal.pone.0063231 
(2013).
 22. Mencia, A. et al. A novel KCNQ4 pore-region mutation (p.G296S) causes deafness by impairing cell-surface channel expression. 
Hum Genet 123, 41–53, https://doi.org/10.1007/s00439-007-0447-7 (2008).
 23. Hildebrand, M. S. et al. Audioprofile-directed screening identifies novel mutations in KCNQ4 causing hearing loss at the DFNA2 
locus. Genet Med 10, 797–804, https://doi.org/10.1097/GIM.0b013e318187e106 (2008).
 24. Baek, J. I. et al. Pathogenic effects of a novel mutation (c.664_681del) in KCNQ4 channels associated with auditory pathology. 
Biochimica et biophysica acta 1812, 536–543, https://doi.org/10.1016/j.bbadis.2010.09.001 (2011).
 25. Van Hauwe, P. et al. Mutations in the KCNQ4 K+channel gene, responsible for autosomal dominant hearing loss, cluster in the 
channel pore region. Am J Med Genet 93, 184–187 (2000).
 26. Lv, P., Wei, D. & Yamoah, E. N. Kv7-type channel currents in spiral ganglion neurons: involvement in sensorineural hearing loss. J 
Biol Chem 285, 34699–34707, https://doi.org/10.1074/jbc.M110.136192 (2010).
 27. Beisel, K. W. et al. Differential expression of KCNQ4 in inner hair cells and sensory neurons is the basis of progressive high-
frequency hearing loss. J Neurosci 25, 9285–9293, https://doi.org/10.1523/JNEUROSCI.2110-05.2005 (2005).
 28. Sun, J. & MacKinnon, R. Cryo-EM Structure of a KCNQ1/CaM Complex Reveals Insights into Congenital Long QT Syndrome. Cell 
169, 1042–1050.e1049, https://doi.org/10.1016/j.cell.2017.05.019 (2017).
 29. Huang, H. et al. Mechanisms of KCNQ1 channel dysfunction in long QT syndrome involving voltage sensor domain mutations. 
Science advances 4, eaar2631, https://doi.org/10.1126/sciadv.aar2631 (2018).
 30. Peroz, D., Dahimene, S., Baro, I., Loussouarn, G. & Merot, J. LQT1-associated mutations increase KCNQ1 proteasomal degradation 
independently of Derlin-1. The Journal of biological chemistry 284, 5250–5256, https://doi.org/10.1074/jbc.M806459200 (2009).
 31. Kim, H. J., Lv, P., Sihn, C. R. & Yamoah, E. N. Cellular and molecular mechanisms of autosomal dominant form of progressive 
hearing loss, DFNA2. J Biol Chem 286, 1517–1527, https://doi.org/10.1074/jbc.M110.179010 (2011).
Acknowledgements
We thank the families for participating in this study. We also thank Yonsei Advanced Imaging Center along 
with Carl Zeiss Microscopy. This study was provided with bioresources from the National Biobank of Korea, 
Centers for Disease Control and Prevention, Republic of Korea (4845-301, 4851-302 and -307). This research was 
supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) 
funded by the Ministry of Education (2015R1D1A1A01056685 to H.Y.G.) and Ministry of Health & Welfare, 
Republic of Korea (2017M3A9E8029721 to J.J.). This work was supported by a grant from the National Research 
Foundation of Korea (NRF) funded by the Korean Government (MSIT; 2016R1D1A1B03934748 to T.M.K. and 
2016M3A9B5941215 to J.Y.C.).
Author Contributions
J.Y.C., T.M.K. and H.Y.G. contributed to the conception and design of this study; J.Y.C. and J.J. referred the 
patients to this study; J.S.L., J.H.R., S.Y.J., S.Y. and H.Y.G. analyzed WES data; Y.I.K. and H.Y.G. performed surface 
biotinylation, immunoprecipitation, and immunofluorescence analyses; H.B.C., J.A., A.K. and T.M.K. performed 
electrophysiological experiments; J.J., J.Y.C., T.M.K. and H.Y.G. performed the data analysis and contributed to 
data interpretation; J.J., J.Y.C., T.M.K. and H.Y.G. wrote manuscript. All the authors revised the manuscript and 
approved the final version submitted for publication.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-34876-9.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
